Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization

@inproceedings{Cascione2019LongNR,
  title={Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization},
  author={Luciano Cascione and Luca Giudice and Serena Ferraresso and Laura Marconato and Diana Giannuzzi and Sara Napoli and Francesco Bertoni and Rosalba Giugno and Luca Aresu},
  booktitle={Non-coding RNA},
  year={2019}
}
BACKGROUND Diffuse large B-cell lymphoma (DLBCL), marginal zone lymphoma (MZL) and follicular lymphoma (FL) are the most common B-cell lymphomas (BCL) in dogs. Recent investigations have demonstrated overlaps of these histotypes with the human counterparts, including clinical presentation, biologic behavior, tumor genetics, and treatment response. The molecular mechanisms that underlie canine BCL are still unknown and new studies to improve diagnosis, therapy, and the utilization of canine… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 36 REFERENCES

Integrated analysis of RNA-seq, MBD-seq and copy number variations in canine marginal zone and follicular lymphoma

D. Giannuzzi, L. Giudice, L. Marconato
  • In Proceedings of the Veterinary Cancer Society Annual Conference,
  • 2019
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2018
VIEW 2 EXCERPTS

Emerging roles of long non-coding RNA in cancer

A. Sanchez Calle, Y. Kawamura, Y. Yamamoto, F. Takeshita, T. Ochiya
  • Cancer Sci
  • 2018
VIEW 1 EXCERPT

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.

  • The New England journal of medicine
  • 2018
VIEW 1 EXCERPT